Market Size of Immunohematology Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 9.20 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Immunohematology Market Analysis
The immunohematology market studied is expected to register an anticipated CAGR of 9.2% over the forecast period.
COVID-19 has impacted market growth. The increased COVID-19 cases and lockdowns imposed by the government all over the world have significantly decreased trauma cases, blood transfusion services, blood donation, and the admission of people suffering from blood disorders to avoid the risk of getting infected by the coronavirus. For instance, according to an article published in Transfusion Therapy and Hemotherapy in April 2022, the Hospitals were compelled to save their supplies in reaction to the decline in blood donations by postponing non-urgent surgeries and organ transplants or reducing transfusion volumes to prevent blood shortages. The same source stated that blood donation rates dropped on average by 38%, while in certain regions, they dropped by as much as 67%. Thus, the decreased blood donations and the demand for immunohematology testing decreased in the blood banks, which has impacted the market growth during the pandemic. Also, the decrease in the number of elective surgical procedures has impacted the market growth. For instance, as per an article published in PLOS One in March 2022, it has been observed that there was a 65.5% decrease in elective cases and a 52.7% decrease in the volume of adult cardiac surgery in the United States. Thus, the decreased number of surgeries and treatment services for patients suffering from blood-related disorders has impacted the demand for hematological testing. However, the resumed services and increased patient visits have increased the market growth and are expected to fuel the market growth over the forecast period.
Factors such as the increasing incidence of trauma and immuno-hematological disorders and technological advancements for the development of new products are expected to boost the market growth.
The incidence and prevalence of blood-related and other chronic disorders such as hemophilia, sickle cell disease, blood cancer, and others are increasing among the population. For instance, according to 2022 statistics published by the Leukemia Foundation, more than 1,35,000 people were living with blood cancer or related blood disorders in Australia in 2022, and this number is projected to reach more than 2,75,000 by 2035. Also, as per the same source, about 19,403 Australians were expected to be diagnosed with blood cancers such as leukemia, lymphoma, and myeloma in 2022. Thus, the increasing prevalence of leukemia and other blood-related cancers among the population is expected to increase the demand for blood transfusion to help treat low blood counts in patients, hence propelling the demand for immunohematology analyzers and screening antibodies over the forecast period.
Moreover, the rising product launches increase the availability of advanced hematology analyzers in the market over the forecast period. For instance, in September 2021, Ortho Clinical Diagnostics launched Immediate Spin Crossmatch (ISXM), ORTHO VISION, and ORTHO VISION MAX Analyzers to aid in detecting incompatibility between donors and recipients in blood transfusions. A serological test, ISXM, is used in blood transfusions to identify ABO blood type incompatibility between recipient serum and plasma and donor red blood cells.
Therefore, owing to the aforementioned factors, such as the high burden of leukemia and blood disorders and new product launches, the studied market is expected to grow over the forecast period. However, the high cost of products and lack of skilled personnel are likely to impede the growth of the immunohematology market over the forecast period.
Immunohematology Industry Segmentation
As per the scope of the report, immunohematology is a branch of hematology and transfusion medicine that investigates antigen-antibody interactions and related phenomena in relation to the pathophysiology and clinical symptoms of blood diseases. For patients with hematological conditions such as auto-immune hemolytic anemia, a wide range of immune-hematological techniques are used to identify and resolve the diagnostic problems in these patients. The immunohematology market is segmented by product (immunohematology analyzers and immunohematology reagents), application (blood typing and antibody screening), end user (hospitals, diagnostic laboratories, and others), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.
By Products | |
Immunohematology Analyzers | |
Immunohematology Reagents |
By Application | |
Blood Typing | |
Antibody Screening |
By End User | |
Hospitals | |
Diagnostic Laboratories | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Immunohematology Market Size Summary
The immunohematology market is poised for significant growth, driven by the increasing incidence of trauma and immuno-hematological disorders, alongside technological advancements in product development. The market experienced a temporary setback due to the COVID-19 pandemic, which led to a decline in blood donations and a reduction in elective surgical procedures, thereby impacting the demand for immunohematology testing. However, as services resumed and patient visits increased, the market began to recover. The rising prevalence of blood-related disorders, such as hemophilia and blood cancers, is expected to propel the demand for blood transfusions and, consequently, immunohematology analyzers and screening antibodies. The introduction of advanced hematology analyzers, like those launched by Ortho Clinical Diagnostics and Grifols, further supports market expansion by enhancing the accuracy and efficiency of blood transfusion compatibility testing.
North America is anticipated to hold a significant share of the immunohematology market, driven by the high burden of immune-hematological disorders and active company engagements in the region. The increasing cases of blood-related disorders necessitate the use of immunohematology testing for antibody-antigen matching in blood transfusions, thereby fueling market growth. The competitive landscape is characterized by the presence of both small and large players, with major companies like Bio-Rad Laboratories, Abbott Laboratories, and Thermo Fisher Scientific actively launching new products and forming strategic partnerships. These developments, coupled with the rising adoption of automated immunohematology instruments, are expected to contribute to the market's growth trajectory over the forecast period.
Immunohematology Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Incidence of Trauma and Immunohematological disorders
-
1.2.2 Technological Advancements for Development of New Products
-
-
1.3 Market Restraints
-
1.3.1 High Cost of Products
-
1.3.2 Lack of Skilled Personnel
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
2.1 By Products
-
2.1.1 Immunohematology Analyzers
-
2.1.2 Immunohematology Reagents
-
-
2.2 By Application
-
2.2.1 Blood Typing
-
2.2.2 Antibody Screening
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Diagnostic Laboratories
-
2.3.3 Others
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Immunohematology Market Size FAQs
What is the current Immunohematology Market size?
The Immunohematology Market is projected to register a CAGR of 9.20% during the forecast period (2024-2029)
Who are the key players in Immunohematology Market?
Grifols S.A. , Immucor Inc. , Thermo Fisher Scientific , Merck KGaA and Abbott Laboratories are the major companies operating in the Immunohematology Market.